• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗病毒药物具有临床重要性的不良反应及药物相互作用。

Adverse effects and drug interactions of clinical importance with antiviral drugs.

作者信息

Morris D J

机构信息

Department of Pathological Sciences, Medical School, Manchester, England.

出版信息

Drug Saf. 1994 Apr;10(4):281-91. doi: 10.2165/00002018-199410040-00002.

DOI:10.2165/00002018-199410040-00002
PMID:8018300
Abstract

Most antiviral drugs are nucleoside analogues with potential teratogenic, embryotoxic, carcinogenic and antiproliferative activities. They must be administered with caution during pregnancy, because some are known teratogens (e.g. amantadine) and a similar propensity cannot be entirely excluded for others (e.g. aciclovir). Their adverse effects mostly involve bone marrow depression (e.g. granulocytopenia with ganciclovir, anaemia with zidovudine) or neurotoxicity (e.g. seizures with interferon-alpha, peripheral neuropathy with zalcitabine), although gastrointestinal effects are also seen. Idiosyncratic reactions include didanosine-induced acute pancreatitis. Only inosine pranobex is largely free from toxicity. Idoxuridine must be administered topically, given the severity of its systemic adverse effects. Drug interactions involving antiviral agents mostly reflect shared toxicity with other agents (e.g. neutropenia with ganciclovir and zidovudine, pancreatitis with didanosine and alcohol), although renal excretion or hepatic metabolism may be implicated. Given the possibility of severe adverse reactions and drug interactions, antiviral chemotherapy should only be used for potentially serious virus infections. Topical administration avoids systemic adverse effects but not mutagenic risks, and may result in exposure of individuals other than the patient (e.g. aerosolised ribavirin).

摘要

大多数抗病毒药物是核苷类似物,具有潜在的致畸、胚胎毒性、致癌和抗增殖活性。孕期使用时必须谨慎,因为有些药物是已知的致畸剂(如金刚烷胺),其他药物(如阿昔洛韦)也不能完全排除类似风险。它们的不良反应主要包括骨髓抑制(如更昔洛韦导致粒细胞减少、齐多夫定导致贫血)或神经毒性(如α干扰素导致癫痫发作、扎西他滨导致周围神经病变),不过也可见胃肠道反应。特异反应包括去羟肌苷引起的急性胰腺炎。只有异丙肌苷基本无毒性。由于碘苷全身不良反应严重,必须局部给药。涉及抗病毒药物的药物相互作用大多反映出与其他药物有共同毒性(如更昔洛韦和齐多夫定导致中性粒细胞减少、去羟肌苷和酒精导致胰腺炎),不过也可能涉及肾脏排泄或肝脏代谢。鉴于可能出现严重不良反应和药物相互作用,抗病毒化疗仅应用于可能严重的病毒感染。局部给药可避免全身不良反应,但无法避免诱变风险,且可能导致患者以外的其他人接触药物(如雾化的利巴韦林)。

相似文献

1
Adverse effects and drug interactions of clinical importance with antiviral drugs.抗病毒药物具有临床重要性的不良反应及药物相互作用。
Drug Saf. 1994 Apr;10(4):281-91. doi: 10.2165/00002018-199410040-00002.
2
Drug interactions with antiviral drugs.抗病毒药物的药物相互作用。
Clin Pharmacokinet. 1996 May;30(5):385-401. doi: 10.2165/00003088-199630050-00005.
3
[Neurotoxicity of antiviral agents].[抗病毒药物的神经毒性]
Ryoikibetsu Shokogun Shirizu. 1999(27 Pt 2):568-70.
4
Drugs for non-HIV viral infections.用于非HIV病毒感染的药物。
Med Lett Drugs Ther. 1997 Aug 1;39(1006):69-76.
5
Comparative pharmacokinetics of antiviral nucleoside analogues.抗病毒核苷类似物的比较药代动力学
Clin Pharmacokinet. 1993 Feb;24(2):101-23. doi: 10.2165/00003088-199324020-00002.
6
[Antiviral treatment].[抗病毒治疗]
Acta Urol Belg. 1993 Jan-Jun;61(1-2):593-8.
7
[Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].[抗病毒化疗的当前进展。第4部分:膦甲酸钠、齐多夫定、去羟肌苷]
Fortschr Med. 1994 May 10;112(13):190-1.
8
Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy.与利巴韦林和去羟肌苷治疗相关的致死性乳酸性酸中毒和胰腺炎。
AIDS Read. 2003 Jul;13(7):344-8.
9
Antiretroviral agents.抗逆转录病毒药物。
IARC Monogr Eval Carcinog Risks Hum. 2000;76:45-173.
10
Studies of zidovudine in combination with didanosine and zalcitabine.齐多夫定与去羟肌苷和扎西他滨联合使用的研究。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S52-6.

引用本文的文献

1
Targeting Key Stages of the Viral Entry and Life Cycle: A Comprehensive Overview of the Mechanisms of Antiviral Actions.靶向病毒进入和生命周期的关键阶段:抗病毒作用机制的全面概述
Methods Mol Biol. 2025;2927:259-286. doi: 10.1007/978-1-0716-4546-8_15.
2
Valacyclovir Induced Neurotoxicity, with Therapeutic Drug Monitoring, in a Hospital-Based Setting in the Netherlands.在荷兰一家医院环境中,伐昔洛韦诱导的神经毒性及治疗药物监测
Eur J Case Rep Intern Med. 2024 Oct 28;11(11):004479. doi: 10.12890/2024_004479. eCollection 2024.
3
Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment.

本文引用的文献

1
Drug interactions with zidovudine.齐多夫定的药物相互作用。
AIDS. 1993 Apr;7(4):445-60. doi: 10.1097/00002030-199304000-00001.
2
Pregnancy outcomes following systemic prenatal acyclovir exposure--June 1, 1984-June 30, 1993.1984年6月1日至1993年6月30日系统性产前暴露于阿昔洛韦后的妊娠结局
MMWR Morb Mortal Wkly Rep. 1993 Oct 22;42(41):806-9.
3
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.
病毒诱导性癫痫与癫痫患者获得病毒感染:为精准治疗揭开复杂关系。
Int J Mol Sci. 2024 Mar 27;25(7):3730. doi: 10.3390/ijms25073730.
4
Medicinal Plants against Viral Infections: A Review of Metabolomics Evidence for the Antiviral Properties and Potentials in Plant Sources.药用植物抗病毒感染:植物源抗病毒特性和潜力的代谢组学证据综述。
Viruses. 2024 Jan 31;16(2):218. doi: 10.3390/v16020218.
5
ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients.ELISPOT 检测 pp65 肽或整个 HCMV 抗原可可靠预测血清阳性肾移植受者对 HCMV 感染的免疫控制。
J Med Virol. 2023 Feb;95(2):e28507. doi: 10.1002/jmv.28507.
6
Novel computational pipelines in antiviral structure‑based drug design (Review).基于抗病毒结构的药物设计中的新型计算流程(综述)
Biomed Rep. 2022 Oct 24;17(6):97. doi: 10.3892/br.2022.1580. eCollection 2022 Dec.
7
Mono- and combinational drug therapies for global viral pandemic preparedness.用于全球病毒大流行防范的单一药物疗法和联合药物疗法。
iScience. 2022 Mar 17;25(4):104112. doi: 10.1016/j.isci.2022.104112. eCollection 2022 Apr 15.
8
Molecular insights of hyaluronic acid-hydroxychloroquine conjugate as a promising drug in targeting SARS-CoV-2 viral proteins.透明质酸-羟氯喹共轭物作为靶向SARS-CoV-2病毒蛋白的一种有前景药物的分子见解。
J Mol Struct. 2021 Aug 15;1238:130457. doi: 10.1016/j.molstruc.2021.130457. Epub 2021 Apr 13.
9
Type I interferons mediate pancreatic toxicities of PERK inhibition.I型干扰素介导PERK抑制的胰腺毒性。
Proc Natl Acad Sci U S A. 2015 Dec 15;112(50):15420-5. doi: 10.1073/pnas.1516362112. Epub 2015 Dec 1.
10
Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells.环丙沙星和更昔洛韦在人巨细胞病毒感染细胞中的代谢。
Antimicrob Agents Chemother. 2014;58(4):2329-33. doi: 10.1128/AAC.02311-13. Epub 2014 Feb 10.
齐多夫定治疗后,对人类免疫缺陷病毒感染患者使用去羟肌苷或扎西他滨的对比试验。艾滋病临床研究特里·贝恩社区项目。
N Engl J Med. 1994 Mar 10;330(10):657-62. doi: 10.1056/NEJM199403103301001.
4
Interferon-alpha in malignant and viral diseases. A review.α干扰素在恶性疾病和病毒性疾病中的应用。综述
Drugs. 1993 Feb;45(2):177-211. doi: 10.2165/00003495-199345020-00003.
5
Common pathways of interferon and hormonal action.干扰素与激素作用的共同途径。
Nature. 1980 Jan 24;283(5745):406-8. doi: 10.1038/283406a0.
6
Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides.蕈样肉芽肿患者接受重组白细胞α干扰素治疗后出现急性间质性肾炎并肾病综合征。
N Engl J Med. 1984 Jan 5;310(1):32-5. doi: 10.1056/NEJM198401053100107.
7
Ribavirin and inosiplex: a review of their present status in viral diseases.利巴韦林与肌苷:它们在病毒性疾病中的现状综述
Drugs. 1981 Aug;22(2):111-28. doi: 10.2165/00003495-198122020-00002.
8
Effects of three recombinant human leukocyte interferons on drug metabolism in mice.三种重组人白细胞干扰素对小鼠药物代谢的影响。
Drug Metab Dispos. 1982 Nov-Dec;10(6):579-85.
9
Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.重组干扰素α-2a(罗扰素)在癌症患者中的安全性和耐受性。
Cancer. 1986 Apr 15;57(8 Suppl):1709-15. doi: 10.1002/1097-0142(19860415)57:8+<1709::aid-cncr2820571315>3.0.co;2-f.
10
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome.重组人粒细胞巨噬细胞集落刺激因子对获得性免疫缺陷综合征骨髓造血的影响。
N Engl J Med. 1987 Sep 3;317(10):593-8. doi: 10.1056/NEJM198709033171003.